About
Biosimilar Production
Areas of Focus
Categories
BiosimilarsSouthwestern U.S.
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
16
As Collaborator
0
Total Enrollment
582
By Phase
NA: 8PHASE3: 2EARLY_PHASE1: 1PHASE2: 2PHASE1/PHASE2: 2PHASE1: 1
By Status
COMPLETED: 12NOT_YET_RECRUITING: 1UNKNOWN: 1ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT04825730Lead Sponsor
Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy
NANot yet recruiting
14 participants
Started: Dec 1, 2023 · Completed: Dec 31, 2029
NCT04821102Lead Sponsor
Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration
NAUnknown
21 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2024
NCT04427930Lead Sponsor
Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
PHASE3Active, not recruiting
129 participants
Started: Apr 13, 2020 · Completed: Dec 30, 2027
NCT03990805Lead Sponsor
A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
PHASE3Completed
260 participants
Started: Jun 11, 2019 · Completed: Dec 15, 2020
NCT03979898Lead Sponsor
Safety and Effectiveness of Autologous Adipose Tissue Derived Mesenchymal Stem Cell Implantation in Patients With CP
EARLY_PHASE1Completed
1 participants
Started: Jun 15, 2017 · Completed: May 13, 2019
Locations (1)
Headquarters
Houston, TX, United States
Map
Loading map...